The Predictive Value of Cystatin C in Monitoring of B Non-Hodgkin Lymphomas: Relation to Biochemical and Clinical Parameters

Table 3

Comparisons of cystatin C levels measured at the time of diagnosis between groups of patients with normal and elevated LDH level, groups of absent and present B symptoms, and groups under and over 60 years of age.

Parameter	Number of patients
	All patients^a	Aggressive	Extranodal	Nodal
LDH
Normal	33	23	13	10
Elevated	19	18	10	8
U	225	120^∗	38	21
P value	0,093	0,022	0,101	0,101
B symptoms
No	12	9	6	3
Yes	40	32	17	15
U	150	94	29	16
P value	0,051	0,120	0,135	0,498
Age
≤60 years	29	23	11	12
>60 years	22	17	11	6
U	191^∗	124	42	21
P value	0,015	0,051	0,243	0,180

∗Statistically significant difference.
^aTotal group of patients.